Points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with ST segment elevation acute myocardial infarction (STEMI)
Points to consider on the requirements for clinical Release for consultation January 2002 documentation for metered dose inhalers (MDI) EMEA Annual Report 2002 65